A 42‐year‐old man with peripheral unspecified T‐cell lymphoma, stage IV, presented with histologically proven bone marrow infiltration, accompanied with bicytopenia (Hb = 6.9 mmol/L, WBC = 1.40 Gpt/L, and Plt = 59 Gpt/L). The blood counts at the beginning of the 3rd cycle of CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisolone) were marked improved: Hb = 7.1 mmol/L, WBC = 4.65 Gpt/L, and Plt = 179 Gpt/L. On day +35 after chemotherapy, the patient developed high‐spiking fever and persistent bicytopenia: Hb = 7.5 mmol/L, WBC = 0.95 Gpt/L, and Plt = 55 Gpt/L. Bone marrow aspiration showed hypercellularity, slightly decreased erythropoiesis and granulopoiesis, slightly increased megakaryopoiesis, and confirmed infiltration by lymphoma. However, in addition, many large cells with an exocentric nucleus with dispersed chromatin and a blue‐gray cytoplasm were found. In these cells -- which represent macrophages -- platelets, erythroblasts, erythrocytes, and lymphoma cells were shown to be phagocytosed (Fig. [1](#ccr3656-fig-0001){ref-type="fig"}). Thus, hemophagocytosis was described. Due to fever, bicytopenia, hemophagocytosis, splenomegaly, hypofibrinogenemia, and elevated ferritin and sIL2 receptor/sCD25, hemophagocytic lymphohistiocytosis (HLH) was diagnosed. Within few days after initiation of prednisolone (100 mg/day for 7 days), the patient\'s condition considerably improved and blood counts were increasing (day +13 after the beginning of prednisolone: Hb = 6.1 mmol/L, WBC = 3.04 mmol/L, and Plt = 142 Gpt/L). Of note, hemophagocytosis and HLH were not present at initial staging.
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Hemophagocytic lymphohistiocytosis is a rare hematological disease with cytopenia and is characterized by cytokine storm and overwhelming inflammation, which is often associated with lymphoma and could be an indicator for treatment resistance. However, due to the HLH definition, HLH can be diagnosed without evident hemophagocytosis.
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